Does vitamin D support immune regulation and antimicrobial-peptide defense through vitamin D receptor signaling in immune cells?

Vitamin D is biologically active in both innate and adaptive immune cells, where locally generated calcitriol signals through the vitamin D receptor (VDR). The overall claim is supported, with stronger mechanistic certainty for antimicrobial-peptide induction than for consistent immunoregulatory effects in humans.

Immune regulation

• In activated human T cells, VDR/RXR signaling can restrain IL2 transcription through antagonism of NFAT/AP-1, reduce IFN-γ and Th1/Th17-associated inflammatory programs, and promote IL-10-related signaling through an IL-6/IL-6R/STAT3 pathway.
• Monocytes, macrophages, dendritic cells, and lymphocytes express VDR; activated monocytes/macrophages and T cells can increase CYP27B1, enabling local conversion of 25(OH)D to calcitriol.
• Supplementation trials show variable changes in T-cell proportions and activation. Effects appear contingent on baseline vitamin-D status, dose, duration, immune activation, cell type, and cytokine environment; they do not establish a uniform clinical immune benefit.

Antimicrobial-peptide defense

• The most direct evidence concerns myeloid cells. TLR2/1 activation increases CYP27B1 and VDR, after which calcitriol-bound VDR/RXR binds a vitamin-D response element in the CAMP promoter.
• This induces hCAP18, the precursor to LL-37, providing a defined VDR-dependent innate-defense mechanism. Experimental evidence shows large CAMP expression increases, although protein responses can be more modest.
• Human supplementation findings are mixed: high-dose cholecalciferol increased circulating LL-37 in one sepsis trial without improving ICU length of stay, while other randomized trials found no significant LL-37, beta-defensin-2, or respiratory-infection benefit.

Bottom line

• Vitamin D supports VDR-mediated immune regulation and antimicrobial-peptide defense. The CAMP/LL-37 mechanism is particularly well established; translating these cellular effects into reliable infection prevention, treatment, or broad clinical immune improvement remains uncertain.